Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years old, and signed informed consent; 2. According to the diagnostic criteria of the ''New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial Version 7)'' issued by the National Health and Health Commission, those who have been diagnosed with CoVID-19 of light and common type. The specific diagnostic criteria are as follows: (1) light type: The clinical symptoms are mild, and there is no pneumonia manifestation in imaging; (2) Common type: It has fever, respiratory tract and other symptoms. Pneumonia can be seen on imaging.
Exclusion criteria
Exclusion criteria: 1. Female patients in pregnancy; 2. Identify patients who are allergic to 4-aminoquinoline compounds. 3. Patients with diseases of the blood system. 4. Patients with liver and kidney disease or those with liver and kidney injury. 5. Patients with arrhythmia and chronic heart disease. 6. Patients with known retinal diseases, hearing loss or hearing loss. 7. Patients with known mental illness. 8. Skin diseases (including rash, dermatitis, psoriasis). 9. Due to the original underlying diseases, digitalis drugs, sparfloxacin, levofloxacin, moxifloxacin, streptomycin, penicillamine, clarithromycin, amiodarone, apomorphine, hydrochlorothiazide, boraxone Heparin, benpredil, domperidone, droperidol, haloperidol, astemizole, erythromycin, posaconazole, methadone, procainamide, cisapride, indapamide, chlorpromazine Patients with azine, ammonium chloride, ondansetron, octreotide monoamine oxidase inhibitors, fluoxyprednisolone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Viral load of nCoV;Blood test;Immunological examination;Blood liver and kidney function test;Myocardial enzyme biochemical examination;ECG examination;Routine urine test;body temperature;pulse;Breathe;blood pressure;CT examination of the lungs; | — |
Countries
China
Contacts
Hongqi Hospital Affiliated to Mudanjiang Medical College